The company will now start a mid-stage trial of the vaccine candidate, ZyCoV-D, in over 1,000 healthy adult volunteers from Thursday to test its effectiveness, it said in a regulatory filing.
The doses of the vaccine administered to healthy volunteers in the phase I clinical trial, which began on July 15 has been well tolerated, Cadila Healthcare, the listed entity of the group, said in the filing. The safety of the vaccine candidate was endorsed by an independent data safety monitoring board.
Continue reading your story on the app
Continue reading your story in the newspaper
‘Forget Cash Reward'
Wrestler Divya’s father narrates humiliation he and his daughter faced for questioning Delhi CM Kejriwal
Why Pak New Map Is A Sham
Pakistan’s move comes exactly a year after India scrapped Art 370
BJP Sends Its 20 MLAs To Gujarat Ahead Of Trust Vote
The BJP has hit out at the Ashok Gehlot-led Congress government in Rajasthan claiming that moral and immoral means were being used in an attempt to induce BJP MLAs before the assembly session which convenes on August 14.
Men WHO Braved Odds To Save Lives
Kozhikode Plane Crash
Gamers In Delhi Easy Prey For Cybercon
Crooks make fake profiles to lure young addicts into buying gaming points, steal money with debit card & e-wallet details
Pak Maintain Firm Grip
Bundle out England for 219 to open 127-run lead on Day 3
Gates Backs Poonawalla With $150 Mn War Chest
Virus vaccine to be rolled out in early 2021
Beirut's Accidental Cargo
An unscheduled stop to pick up extra cargo led to the disaster
Virus Wreaks Havoc In U.S. As 2,060 Die In Single Day
Europe remains the hardest-hit region globally with 200K deaths
Why Chennai Fears Abeirut Redux
Presence of 740 tonnes of ammonium nitrate at Sattva freight station raises safety concerns